Takeda To Establish New Subsidiary In Brazil

Takeda Pharmaceutical Company (Takeda) is planning to establish a new commercial subsidiary in Brazil.

The new subsidiary represents the 12th new strategic expansion since January 2009 including Canada, Spain, Portugal, Ireland, Mexico, Sweden, Norway, Denmark, Belgium, Luxembourg and Turkey.

The company said that the new subsidiary will import and commercialise Takeda products for the Brazilian market. Upon establishment, Takeda is also expected to build the infrastructure necessary for success in the Brazilian pharmaceutical market.

Alan MacKenzie, executive vice president of international operations at Takeda Pharmaceuticals International, said: “Combined with Takeda’s additional recent expansions, this opportunity will drive Takeda’s ability to maximise the potential of our pipeline in Brazil. Brazil is an important country in the Latin American region for Takeda to ensure we are providing our products where patients need them.”